Bio-Techne Corp
TECH Healthcare Biotechnology
Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025. In the quarter to June 2026, revenue grew 1.33%, EPS grew 418.2%, free cash flow fell 6.83% and total debt fell 42.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years.
Follow TECH
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
264.71 | 209.82 | 172.88 | 144.96 |
+8 more quarters Free account |
Receivables |
216.59 | 214.56 | 184.61 | 183.90 | |
Inventory |
195.74 | 201.18 | 205.45 | 203.19 | |
Other current assets |
67.36 | 62.49 | 74.49 | 77.46 | |
Total current assets |
744.40 | 688.05 | 637.43 | 609.51 | |
Property, Plant, Equpment (Net) |
231.84 | 232.99 | 234.38 | 240.33 | |
Goodwill and Intangible Assets (Total) |
1,278.82 | 1,296.87 | 1,315.55 | 1,329.02 | |
Long-term assets (Other) |
264.34 | 264.37 | 267.08 | 276.56 | |
Total non-current assets |
1,842.33 | 1,862.55 | 1,885.27 | 1,916.64 | |
Total Assets |
2,586.73 | 2,550.60 | 2,522.70 | 2,526.15 | |
Accounts Payable |
26.70 | 23.49 | 26.27 | 30.16 | |
Accrued Expenses |
78.38 | 72.11 | 65.36 | 62.78 | |
Current Part of Taxes to Pay |
3.59 | 2.97 | 2.48 | 2.85 | |
Other current liabilities |
40.10 | 40.53 | 32.61 | 34.99 | |
Total current liabilities |
163.70 | 153.28 | 140.43 | 144.55 | |
Long Term Debt (Total) |
200.00 | 200.00 | 260.00 | 300.00 | |
Long Term Tax Liability (Deferred) |
19.31 | 14.21 | 11.02 | 11.27 | |
Non-current Liabilities (Other) |
21.35 | 21.67 | 23.08 | 23.81 | |
Total non-current liabilities |
314.81 | 312.02 | 371.28 | 415.79 | |
Total liabilities |
478.51 | 465.30 | 511.71 | 560.33 | |
Additional Paid In Capital |
1,033.05 | 1,005.40 | 964.96 | 946.12 | |
Common Stock (Net) |
1.56 | 1.57 | 1.56 | 1.56 | |
Retained Earnings |
1,144.19 | 1,145.19 | 1,106.82 | 1,082.53 | |
Common Equity (Total) |
2,108.22 | 2,085.30 | 2,010.99 | 1,965.81 | |
Shareholders Equity (Total) |
2,108.22 | 2,085.30 | 2,010.99 | 1,965.81 | |
Shareholders Equity and Liabilities (Total) |
2,586.73 | 2,550.60 | 2,522.70 | 2,526.15 | |
Shares (Common) |
156.10 | 156.52 | 155.88 | 155.75 | |
Shareholders Equity (Tangible) |
829.40 | 788.43 | 695.44 | 636.79 | |
Net Debt |
(64.71) | (9.82) | 87.12 | 155.04 | |
Total Debt |
200.00 | 200.00 | 260.00 | 300.00 |